Which patients, in your view, are not candidates for PCSK9 inhibition?

Which patients, in your view, are not candidates for PCSK9 inhibition?

Which patients, in your view, are not candidates for PCSK9 inhibition?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Lipidologist and Atherosclerosis Specialist's Perspective

Presenter

Anne C. Goldberg, MD, FNLA, FACP, FAHA

Anne C. Goldberg, MD, FNLA, FACP, FAHA

Professor of Medicine Division of Endocrinology, Metabolism & Lipid Research Washington University in St. Louis St. Louis, MO